emepepimut-S

{
  "id": "MLC-T-ONC-013321",
  "term": "emepepimut-S",
  "field": "Oncology and biomedicine",
  "definition": "A liposome-encapsulated peptide vaccine consisting of a synthetic peptide derived from the mucin 1 (MUC-1) antigen with potential antineoplastic activity. Upon vaccination, emepepimut-S may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against MUC-1-expressing tumor cells, resulting in growth inhibition. MUC-1 antigen is a high-molecular-weight transmembrane glycoprotein that is overexpressed on the cell surfaces of many epithelial tumor cells as well as on the cell surfaces of some B-cell lymphoma cells and multiple myeloma cells.",
  "abbreviation": "BP1-7-KLH",
  "synonyms": [
    "tecemotide",
    "liposomal BLP25 vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/emepepimut-s/"
}